Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
SERCA PHARMACEUTICALS AS
AS
Active
Org 921663846
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
0 employees
Overvåg
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SERCA PHARMACEUTICALS AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
KH
Kjetil Hestdal
Chief Executive Officer
Chief Executive Officer
2018
Former (1)
FA
Farzad Abdi-Dezfuli
Observer
Observer
2019 – 2024
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (3)
KS
Kristin Sandereid
Board of Directors
Board of Directors
2019
EP
Erlend Petter Skagseth
Chairman
Chairman
2019
JH
Jens Halvard Grønlien
Board of Directors
Board of Directors
2024
Former (1)
EA
Erik Amble
Board of Directors
Board of Directors
2019 – 2024
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Sarsia Seed Fond Ii As
Company
40.45%
40.45%
2025
Inven2 As
Company
26.13%
26.13%
2025
Saturn Invest As
Company
10.9%
10.9%
2025
Mp Pensjon Pk
Company
9.09%
9.09%
2025
Herseth As
Company
4.47%
4.47%
2025
K Og K As
Company
2.61%
2.61%
2025
Ifh Consulting As
Company
2.49%
2.49%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on SERCA PHARMACEUTICALS AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network